Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-05-08

DOI:

10.1200/jco-25-00131

Affiliations:

13

Authors:

34

Go to article

Institutions	Authors	Share
Johns Hopkins University (JHU), United States of America (USA)	10.500000 10.500000	0.31
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	7.500000	0.22
Mayo Clinic, United States of America (USA)	4.000000	0.12
University of Maryland, Baltimore (UMB), United States of America (USA)	3.500000	0.10
University of Miami (UM), United States of America (USA)	2.000000	0.06
The University of Texas MD Anderson Cancer Center, United States of America (USA)	2.000000	0.06
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	2.000000	0.06
Rutgers Cancer Institute of New Jersey (CINJ), United States of America (USA)	1.000000	0.03
Princess Margaret Cancer Centre, U of T, Canada	1.000000	0.03
University of Rochester Medical Center (URMC), UR, United States of America (USA)	0.500000	0.01

Interested in Oncology and Carcinogenesis?